Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Serine/threonine-protein kinase B-raf | ||
Ligand | BDBM50330915 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_685663 (CHEMBL1285565) | ||
IC50 | 0.770000±n/a nM | ||
Citation | Wang, X; Berger, DM; Salaski, EJ; Torres, N; Dutia, M; Hanna, C; Hu, Y; Levin, JI; Powell, D; Wojciechowicz, D; Collins, K; Frommer, E; Lucas, J Indazolylpyrazolopyrimidine as highly potent B-Raf inhibitors with in vivo activity. J Med Chem53:7874-8 (2010) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Serine/threonine-protein kinase B-raf | |||
Name: | Serine/threonine-protein kinase B-raf | ||
Synonyms: | B-RAF | B-Raf Protein Kinase | B-Raf proto-oncogene serine/threonine-protein kinase | BRAF | BRAF1 | BRAF_HUMAN | RAFB1 | p94 | v-Raf murine sarcoma viral oncogene homolog B1 | ||
Type: | Serine/threonine-protein kinase | ||
Mol. Mass.: | 84446.00 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P15056 | ||
Residue: | 766 | ||
Sequence: |
| ||
BDBM50330915 | |||
n/a | |||
Name | BDBM50330915 | ||
Synonyms: | 9-(4-(3-(1H-indazol-4-yl)-2-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidin-7-yl)-3-fluorobenzyl)-3,7-dioxa-9-azabicyclo[3.3.1]nonane | CHEMBL1276192 | ||
Type | Small organic molecule | ||
Emp. Form. | C31H26FN7O2 | ||
Mol. Mass. | 547.5822 | ||
SMILES | Fc1cc(CN2C3COCC2COC3)ccc1-c1ccnc2c(c(nn12)-c1ccncc1)-c1cccc2[nH]ncc12 |(13.8,-22.79,;15.13,-22.01,;15.12,-20.47,;16.4,-19.69,;16.45,-18.15,;17.8,-17.42,;18.65,-16.43,;18.72,-14.73,;20.2,-14.56,;19.38,-15.46,;19.29,-17.23,;21.11,-17.39,;21.5,-15.89,;20.4,-16.61,;17.79,-20.46,;17.8,-22,;16.46,-22.77,;16.47,-24.31,;15.14,-25.08,;15.14,-26.62,;16.47,-27.39,;17.81,-26.62,;19.28,-27.1,;20.19,-25.84,;19.28,-24.59,;17.81,-25.07,;21.73,-25.84,;22.5,-27.18,;24.04,-27.18,;24.81,-25.84,;24.03,-24.5,;22.5,-24.51,;19.76,-28.56,;21.26,-28.88,;21.74,-30.34,;20.71,-31.49,;19.2,-31.17,;17.95,-32.07,;16.71,-31.16,;17.2,-29.7,;18.73,-29.71,)| | ||
Structure |